Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IV Lidocaine for Tinnitus
NCT04192773Phase 1Recruiting
- Start
- Apr 2021
- Primary completion
- Dec 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of Lidocaine Hydrochloride Injection, without epinephrine in tinnitus. Primary endpoint: Compare fMRI scans pre- and post-lidocaine administration to identify neural networks associated with chronic tinnitus at 60 minutes. Started Apr 2021; status: recruiting.
02
Drugs
Lidocaine Hydrochloride Injection, without epinephrine
03
Conditions
tinnitus
Beyond the preview
Go deeper on NCT04192773.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04192773.